<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d334">
    <sentence id="DDI-DrugBank.d334.s0" text="Hypotension - Patients on Diuretic Therapy: Patients on diuretics, and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with PRINIVIL.">
        <entity charOffset="56-64" id="DDI-DrugBank.d334.s0.e0" text="diuretics" type="group"/>
        <entity charOffset="240-247" id="DDI-DrugBank.d334.s0.e1" text="PRINIVIL" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s0.e0" e2="DDI-DrugBank.d334.s0.e1" id="DDI-DrugBank.d334.s0.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s1" text="The possibility of hypotensive effects with PRINIVIL can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with PRINIVIL.">
        <entity charOffset="44-51" id="DDI-DrugBank.d334.s1.e0" text="PRINIVIL" type="brand"/>
        <entity charOffset="98-105" id="DDI-DrugBank.d334.s1.e1" text="diuretic" type="group"/>
        <entity charOffset="175-182" id="DDI-DrugBank.d334.s1.e2" text="PRINIVIL" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s1.e0" e2="DDI-DrugBank.d334.s1.e1" id="DDI-DrugBank.d334.s1.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s1.e0" e2="DDI-DrugBank.d334.s1.e2" id="DDI-DrugBank.d334.s1.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s1.e1" e2="DDI-DrugBank.d334.s1.e2" id="DDI-DrugBank.d334.s1.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s2" text="If it is necessary to continue the diuretic, initiate therapy with PRINIVIL at a dose of 5 mg daily, and provide close medical supervision after the initial dose until blood pressure has stabilized.">
        <entity charOffset="35-42" id="DDI-DrugBank.d334.s2.e0" text="diuretic" type="group"/>
        <entity charOffset="67-74" id="DDI-DrugBank.d334.s2.e1" text="PRINIVIL" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s2.e0" e2="DDI-DrugBank.d334.s2.e1" id="DDI-DrugBank.d334.s2.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s3" text="When a diuretic is added to the therapy of a patient receiving PRINIVIL, an additional antihypertensive effect is usually observed.">
        <entity charOffset="7-14" id="DDI-DrugBank.d334.s3.e0" text="diuretic" type="group"/>
        <entity charOffset="63-70" id="DDI-DrugBank.d334.s3.e1" text="PRINIVIL" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s3.e0" e2="DDI-DrugBank.d334.s3.e1" id="DDI-DrugBank.d334.s3.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s4" text="Studies with ACE inhibitors in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic.">
        <entity charOffset="13-26" id="DDI-DrugBank.d334.s4.e0" text="ACE inhibitors" type="group"/>
        <entity charOffset="48-56" id="DDI-DrugBank.d334.s4.e1" text="diuretics" type="group"/>
        <entity charOffset="88-100" id="DDI-DrugBank.d334.s4.e2" text="ACE inhibitor" type="group"/>
        <entity charOffset="141-148" id="DDI-DrugBank.d334.s4.e3" text="diuretic" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s4.e0" e2="DDI-DrugBank.d334.s4.e1" id="DDI-DrugBank.d334.s4.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s4.e0" e2="DDI-DrugBank.d334.s4.e2" id="DDI-DrugBank.d334.s4.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s4.e0" e2="DDI-DrugBank.d334.s4.e3" id="DDI-DrugBank.d334.s4.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s4.e1" e2="DDI-DrugBank.d334.s4.e2" id="DDI-DrugBank.d334.s4.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s4.e1" e2="DDI-DrugBank.d334.s4.e3" id="DDI-DrugBank.d334.s4.p4"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s4.e2" e2="DDI-DrugBank.d334.s4.e3" id="DDI-DrugBank.d334.s4.p5" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s5" text="Non-steroidal Anti-inflammatory Agents: In some patients with compromised renal function who are being treated with non-steroidal anti-inflammatory drugs, the co-administration of lisinopril may result in a further deterioration of renal function.">
        <entity charOffset="0-37" id="DDI-DrugBank.d334.s5.e0" text="Non-steroidal Anti-inflammatory Agents" type="group"/>
        <entity charOffset="116-152" id="DDI-DrugBank.d334.s5.e1" text="non-steroidal anti-inflammatory drugs" type="group"/>
        <entity charOffset="180-189" id="DDI-DrugBank.d334.s5.e2" text="lisinopril" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s5.e0" e2="DDI-DrugBank.d334.s5.e1" id="DDI-DrugBank.d334.s5.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s5.e0" e2="DDI-DrugBank.d334.s5.e2" id="DDI-DrugBank.d334.s5.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s5.e1" e2="DDI-DrugBank.d334.s5.e2" id="DDI-DrugBank.d334.s5.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s6" text="These effects are usually reversible."/>
    <sentence id="DDI-DrugBank.d334.s7" text="Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors, including lisinopril.">
        <entity charOffset="21-26" id="DDI-DrugBank.d334.s7.e0" text="NSAIDs" type="group"/>
        <entity charOffset="72-85" id="DDI-DrugBank.d334.s7.e1" text="ACE inhibitors" type="group"/>
        <entity charOffset="98-107" id="DDI-DrugBank.d334.s7.e2" text="lisinopril" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s7.e0" e2="DDI-DrugBank.d334.s7.e1" id="DDI-DrugBank.d334.s7.p0" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s7.e0" e2="DDI-DrugBank.d334.s7.e2" id="DDI-DrugBank.d334.s7.p1" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s7.e1" e2="DDI-DrugBank.d334.s7.e2" id="DDI-DrugBank.d334.s7.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s8" text="This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE inhibitors.">
        <entity charOffset="66-71" id="DDI-DrugBank.d334.s8.e0" text="NSAIDs" type="group"/>
        <entity charOffset="92-105" id="DDI-DrugBank.d334.s8.e1" text="ACE inhibitors" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s8.e0" e2="DDI-DrugBank.d334.s8.e1" id="DDI-DrugBank.d334.s8.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s9" text="In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.">
        <entity charOffset="99-106" id="DDI-DrugBank.d334.s9.e0" text="PRINIVIL" type="brand"/>
        <entity charOffset="131-138" id="DDI-DrugBank.d334.s9.e1" text="PRINIVIL" type="brand"/>
        <entity charOffset="165-176" id="DDI-DrugBank.d334.s9.e2" text="indomethacin" type="drug"/>
        <entity charOffset="190-201" id="DDI-DrugBank.d334.s9.e3" text="indomethacin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s9.e0" e2="DDI-DrugBank.d334.s9.e1" id="DDI-DrugBank.d334.s9.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s9.e0" e2="DDI-DrugBank.d334.s9.e2" id="DDI-DrugBank.d334.s9.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s9.e0" e2="DDI-DrugBank.d334.s9.e3" id="DDI-DrugBank.d334.s9.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s9.e1" e2="DDI-DrugBank.d334.s9.e2" id="DDI-DrugBank.d334.s9.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s9.e1" e2="DDI-DrugBank.d334.s9.e3" id="DDI-DrugBank.d334.s9.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s9.e2" e2="DDI-DrugBank.d334.s9.e3" id="DDI-DrugBank.d334.s9.p5"/>
    <negationtags>In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; significant. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d334.s10" text="Other Agents: PRINIVIL has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions.">
        <entity charOffset="14-21" id="DDI-DrugBank.d334.s10.e0" text="PRINIVIL" type="brand"/>
        <entity charOffset="56-63" id="DDI-DrugBank.d334.s10.e1" text="nitrates" type="group"/>
        <entity charOffset="72-78" id="DDI-DrugBank.d334.s10.e2" text="digoxin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s10.e0" e2="DDI-DrugBank.d334.s10.e1" id="DDI-DrugBank.d334.s10.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s10.e0" e2="DDI-DrugBank.d334.s10.e2" id="DDI-DrugBank.d334.s10.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s10.e1" e2="DDI-DrugBank.d334.s10.e2" id="DDI-DrugBank.d334.s10.p2"/>
    <negationtags>Other Agents: PRINIVIL has been used concomitantly with nitrates and/or digoxin &lt;scope&gt; &lt;cue&gt; without evidence &lt;/cue&gt; of clinically significant adverse interactions. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d334.s11" text="This included post myocardial infarction patients who were receiving intravenous or transdermal nitroglycerin.">
        <entity charOffset="96-108" id="DDI-DrugBank.d334.s11.e0" text="nitroglycerin" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s12" text="No clinically important pharmacokinetic interactions occurred when PRINIVIL was used concomitantly with propranolol or hydrochlorothiazide.">
        <entity charOffset="67-74" id="DDI-DrugBank.d334.s12.e0" text="PRINIVIL" type="brand"/>
        <entity charOffset="104-114" id="DDI-DrugBank.d334.s12.e1" text="propranolol" type="drug"/>
        <entity charOffset="119-137" id="DDI-DrugBank.d334.s12.e2" text="hydrochlorothiazide" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s12.e0" e2="DDI-DrugBank.d334.s12.e1" id="DDI-DrugBank.d334.s12.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s12.e0" e2="DDI-DrugBank.d334.s12.e2" id="DDI-DrugBank.d334.s12.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s12.e1" e2="DDI-DrugBank.d334.s12.e2" id="DDI-DrugBank.d334.s12.p2"/>
    <negationtags>&lt;scope&gt; &lt;cue&gt; No &lt;/cue&gt; clinically important pharmacokinetic interactions occurred when PRINIVIL was used concomitantly with propranolol or hydrochlorothiazide. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d334.s13" text="The presence of food in the stomach does not alter the bioavailability of PRINIVIL.">
        <entity charOffset="74-81" id="DDI-DrugBank.d334.s13.e0" text="PRINIVIL" type="brand"/>
    <negationtags>The presence of food in the stomach does &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; alter the bioavailability of PRINIVIL. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d334.s14" text="Agents Increasing Serum Potassium: PRINIVIL attenuates potassium loss caused by thiazide-type diuretics.">
        <entity charOffset="35-42" id="DDI-DrugBank.d334.s14.e0" text="PRINIVIL" type="brand"/>
        <entity charOffset="80-102" id="DDI-DrugBank.d334.s14.e1" text="thiazide-type diuretics" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s14.e0" e2="DDI-DrugBank.d334.s14.e1" id="DDI-DrugBank.d334.s14.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s15" text="Use of PRINIVIL with potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.">
        <entity charOffset="7-14" id="DDI-DrugBank.d334.s15.e0" text="PRINIVIL" type="brand"/>
        <entity charOffset="21-47" id="DDI-DrugBank.d334.s15.e1" text="potassium-sparing diuretics" type="group"/>
        <entity charOffset="56-69" id="DDI-DrugBank.d334.s15.e2" text="spironolactone" type="drug"/>
        <entity charOffset="72-82" id="DDI-DrugBank.d334.s15.e3" text="triamterene" type="drug"/>
        <entity charOffset="88-96" id="DDI-DrugBank.d334.s15.e4" text="amiloride" type="drug"/>
        <entity charOffset="100-108" id="DDI-DrugBank.d334.s15.e5" text="potassium" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s15.e0" e2="DDI-DrugBank.d334.s15.e1" id="DDI-DrugBank.d334.s15.p0" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s15.e0" e2="DDI-DrugBank.d334.s15.e2" id="DDI-DrugBank.d334.s15.p1" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s15.e0" e2="DDI-DrugBank.d334.s15.e3" id="DDI-DrugBank.d334.s15.p2" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s15.e0" e2="DDI-DrugBank.d334.s15.e4" id="DDI-DrugBank.d334.s15.p3" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s15.e0" e2="DDI-DrugBank.d334.s15.e5" id="DDI-DrugBank.d334.s15.p4" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e1" e2="DDI-DrugBank.d334.s15.e2" id="DDI-DrugBank.d334.s15.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e1" e2="DDI-DrugBank.d334.s15.e3" id="DDI-DrugBank.d334.s15.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e1" e2="DDI-DrugBank.d334.s15.e4" id="DDI-DrugBank.d334.s15.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e1" e2="DDI-DrugBank.d334.s15.e5" id="DDI-DrugBank.d334.s15.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e2" e2="DDI-DrugBank.d334.s15.e3" id="DDI-DrugBank.d334.s15.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e2" e2="DDI-DrugBank.d334.s15.e4" id="DDI-DrugBank.d334.s15.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e2" e2="DDI-DrugBank.d334.s15.e5" id="DDI-DrugBank.d334.s15.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e3" e2="DDI-DrugBank.d334.s15.e4" id="DDI-DrugBank.d334.s15.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e3" e2="DDI-DrugBank.d334.s15.e5" id="DDI-DrugBank.d334.s15.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s15.e4" e2="DDI-DrugBank.d334.s15.e5" id="DDI-DrugBank.d334.s15.p14"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s16" text="Therefore, if concomitant use of these agents is indicated because of demonstrated hypokalemia, they should be used with caution and with frequent monitoring of serum potassium."/>
    <sentence id="DDI-DrugBank.d334.s17" text="Potassium sparing agents should generally not be used in patients with heart failure who are receiving PRINIVIL.">
        <entity charOffset="103-110" id="DDI-DrugBank.d334.s17.e0" text="PRINIVIL" type="brand"/>
    <negationtags>Potassium sparing agents should generally &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be used in patients with heart failure who are receiving PRINIVIL. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d334.s18" text="Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.">
        <entity charOffset="0-6" id="DDI-DrugBank.d334.s18.e0" text="Lithium" type="drug"/>
        <entity charOffset="9-15" id="DDI-DrugBank.d334.s18.e1" text="Lithium" type="drug"/>
        <entity charOffset="66-72" id="DDI-DrugBank.d334.s18.e2" text="lithium" type="drug"/>
        <entity charOffset="144-157" id="DDI-DrugBank.d334.s18.e3" text="ACE inhibitors" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s18.e0" e2="DDI-DrugBank.d334.s18.e1" id="DDI-DrugBank.d334.s18.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s18.e0" e2="DDI-DrugBank.d334.s18.e2" id="DDI-DrugBank.d334.s18.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s18.e0" e2="DDI-DrugBank.d334.s18.e3" id="DDI-DrugBank.d334.s18.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s18.e1" e2="DDI-DrugBank.d334.s18.e2" id="DDI-DrugBank.d334.s18.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s18.e1" e2="DDI-DrugBank.d334.s18.e3" id="DDI-DrugBank.d334.s18.p4"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s18.e2" e2="DDI-DrugBank.d334.s18.e3" id="DDI-DrugBank.d334.s18.p5" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s19" text="Lithium toxicity was usually reversible upon discontinuation of lithium and the ACE inhibitor.">
        <entity charOffset="0-6" id="DDI-DrugBank.d334.s19.e0" text="Lithium" type="drug"/>
        <entity charOffset="64-70" id="DDI-DrugBank.d334.s19.e1" text="lithium" type="drug"/>
        <entity charOffset="80-92" id="DDI-DrugBank.d334.s19.e2" text="ACE inhibitor" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s19.e0" e2="DDI-DrugBank.d334.s19.e1" id="DDI-DrugBank.d334.s19.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s19.e0" e2="DDI-DrugBank.d334.s19.e2" id="DDI-DrugBank.d334.s19.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s19.e1" e2="DDI-DrugBank.d334.s19.e2" id="DDI-DrugBank.d334.s19.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d334.s20" text="It is recommended that serum lithium levels be monitored frequently if PRINIVIL is administered concomitantly with lithium.">
        <entity charOffset="29-35" id="DDI-DrugBank.d334.s20.e0" text="lithium" type="drug"/>
        <entity charOffset="71-78" id="DDI-DrugBank.d334.s20.e1" text="PRINIVIL" type="brand"/>
        <entity charOffset="115-121" id="DDI-DrugBank.d334.s20.e2" text="lithium" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s20.e0" e2="DDI-DrugBank.d334.s20.e1" id="DDI-DrugBank.d334.s20.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d334.s20.e0" e2="DDI-DrugBank.d334.s20.e2" id="DDI-DrugBank.d334.s20.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d334.s20.e1" e2="DDI-DrugBank.d334.s20.e2" id="DDI-DrugBank.d334.s20.p2" type="advise"/>
    </sentence>
</document>